Rare Tumors

Jeffrey Buchsbaum, MD, PhD, AM

Medical Officer and Program Director
Radiation Research Program
National Cancer Institute, NIH

Jeff Buchsbaum joined the RRP Clinical Radiation Oncology Branch as the next step in his academic career that includes graduating from Dartmouth College, receiving his MD, PhD from Johns Hopkins (Dept. of Molecular Biophysics and Biophysical Chemistry (Advisor: Jeremy Berg, PhD)), completing his residency in Radiation Oncology at the Cleveland Clinic and subsequent advanced training and faculty positions in pediatric oncology including St. Jude. He joins us from Indiana University where he was a leader at the proton facility and recently promoted to Professor. His breadth of clinical and research skills adds important dimensions to the DCTD programs and ongoing radiation research efforts involving other federal agencies as well as the CCR, where he will be treating pediatric patients at the Radiation Oncology Branch.

Matthew Krasin, MD

Faculty, Radiation Oncology
St. Jude Research Hospital

Dr. Krasin’s focus in his clinical and academic work has centered on pediatric sarcomas and Hodgkin’s disease. He joined the Radiation Oncology faculty in July 2000 and has developed a research program studying focal radiation therapy as applied to patients with rhabdomyosarcoma, Ewing’s sarcoma, soft-tissue sarcomas and Hodgkin’s disease. His studies seek to maximize local tumor control and survival with radiation therapy, employing the most modern technologies (conformal, IMRT and brachytherapy treatment). While achieving cure is paramount, cure without quality of life is unsatisfactory. Therefore, these studies also systematically integrate treatment approaches to further reduce the side effects of radiation. The RT-SARC and Hodgkin’s clinical trials integrate MRI and PET imaging for targeting to deliver highly focused radiation for treatment. Published outcomes have been excellent, confirming the validity of this approach.